Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.6300
-0.0300 (-1.81%)
NASDAQ· Last Trade: Jun 6th, 2:21 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors